Cutting Edge: FcR-Like 5 on Innate B Cells Is Targeted by a Poxvirus MHC Class I-Like Immunoevasin

被引:23
|
作者
Campbell, Jessica A. [1 ]
Davis, Randall S. [4 ,5 ]
Lilly, Lauren M. [4 ]
Fremont, Daved H. [2 ]
French, Anthony R. [1 ]
Carayannopoulos, Leonidas N. [3 ]
机构
[1] Washington Univ, Dept Pediat, Div Pediat Rheumatol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[3] Washington Univ, Div Pulm & Crit Care Med, Dept Internal Med, St Louis, MO 63110 USA
[4] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 01期
关键词
MARGINAL ZONE; INFLUENZA-VIRUS; NK CELLS; RECEPTOR; ACTIVATION; NKG2D; EXPRESSION; MACROPHAGES; FAMILY;
D O I
10.4049/jimmunol.1000240
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Under selective pressure from host immunity, viruses have retained genes encoding immunoevasins, molecules interfering with host viral recognition and clearance. Due to their binding specificities, immunoevasins can be exploited as affinity labels to identify host-encoded molecules of previously unsuspected importance in defense against the relevant class of virus. We previously described an orthopoxvirus MHC class I-like protein (OMCP) that binds with high affinity to the activating receptor NKG2D on NK and T cell subsets, implicating NKG2D in antiorthopoxvirus immunity. In this study, we report that OMCP also binds in an NKG2D-independent manner to B cells and monocytes/macrophages. We identify murine FcR-like 5 (FCRL5), an orphan immunoregulatory protein highly expressed by innate B lymphocytes, as a specific receptor for OMCP. The three N-terminal Ig domains of FCRL5 are required for OMCP binding. The targeting of FCRL5 by an orthopoxvirus immunoevasin strongly implicates it in contributing to host defense against zoonotic orthopoxviruses. The Journal of Immunology, 2010, 185: 28-32.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 50 条
  • [1] Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor
    Schreeder, Daniel M.
    Cannon, John P.
    Wu, Jiongru
    Li, Ran
    Shakhmatov, Mikhail A.
    Davis, Randall S.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (01): : 23 - 27
  • [2] Response to Comment on "Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor"
    Schreeder, Daniel M.
    Davis, Randall S.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09): : 4965 - 4966
  • [3] Evolution of innate-like T cells and their selection by MHC class I-like molecules
    Eva-Stina Edholm
    Maureen Banach
    Jacques Robert
    Immunogenetics, 2016, 68 : 525 - 536
  • [4] Evolution of innate-like T cells and their selection by MHC class I-like molecules
    Edholm, Eva-Stina
    Banach, Maureen
    Robert, Jacques
    IMMUNOGENETICS, 2016, 68 (08) : 525 - 536
  • [5] Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus
    Banach, Maureen
    Edholm, Eva-Stina
    Gonzalez, Xavier
    Benraiss, Abdellatif
    Robert, Jacques
    CARCINOGENESIS, 2019, 40 (07) : 924 - 935
  • [6] Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation
    Ugolini, S
    Vivier, E
    NATURE IMMUNOLOGY, 2001, 2 (03) : 198 - 200
  • [7] CLASS I-LIKE MHC MOLECULES EXPRESSED BY BABOON PLACENTAL SYNCYTIOTROPHOBLAST
    STERN, PL
    BERESFORD, N
    FRIEDMAN, CI
    STEVENS, VC
    RISK, JM
    JOHNSON, PM
    JOURNAL OF IMMUNOLOGY, 1987, 138 (04): : 1088 - 1091
  • [8] Cloning and characterization of the bovine MHC class I-like Fc receptor
    Kacskovics, I
    Wu, Z
    Simister, NE
    Frenyó, LV
    Hammarström, L
    JOURNAL OF IMMUNOLOGY, 2000, 164 (04): : 1889 - 1897
  • [9] FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells
    Jackson, Tanisha A.
    Haga, Christopher L.
    Ehrhardt, Goetz R. A.
    Davis, Randall S.
    Cooper, Max D.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (12): : 7405 - 7412
  • [10] A novel MHC class I-like gene is mutated in patients with hemochromatosis
    Feder, JN
    Gnirke, A
    Thomas, W
    Tsuchihashi, Z
    Ruddy, DA
    Risch, NJ
    Bacon, BR
    Wolff, RK
    BLOOD, 1996, 88 (10) : 2579 - 2579